Korsana Biosciences, Inc. KRSA

US Biotechnology

$30.03 ▼ -3.66% ($-1.14)

🎈 Low Float

Open $31.00

Prev Close $31.17

Day Range $30.00 – $32.31

52W Range $21.00 – $37.27

Market Cap $1.42B

Beta 6.03

EPS (TTM) $-1.68

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2019-03-18
Shares Out.	45,540,000
Website	korsana.com ↗
Phone	18573278778

About Korsana Biosciences, Inc.

Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.

Korsana Biosciences, Inc. is a publicly traded company under the ticker symbol KRSA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.